Insider Transactions in Q2 2021 at Oyster Point Pharma, Inc. (OYST)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2021
|
Michael G Atieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+13.02%
|
-
|
|
Jun 07
2021
|
William J Phd Link Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
|
Jun 07
2021
|
Mark Anthony Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+2.84%
|
-
|
|
Jun 07
2021
|
Benjamin Tsai Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
|
Jun 07
2021
|
Aimee S Weisner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+9.46%
|
-
|
|
Jun 07
2021
|
Ali Behbahani Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+25.61%
|
-
|
|
Jun 07
2021
|
George Christopher Eliades Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+12.15%
|
-
|
|
Jun 07
2021
|
Clare Ozawa Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,466
+24.25%
|
-
|
|
May 12
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
10,944
+33.43%
|
-
|
|
May 12
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
404,844
-46.12%
|
-
|
|
May 12
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
193
+2.56%
|
-
|
|
May 12
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
82,486
+50.0%
|
-
|
|
May 12
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
404,844
-46.12%
|
-
|
|
May 12
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
82,486
+50.0%
|
-
|
|
Apr 02
2021
|
George Christopher Eliades Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,585
+28.55%
|
-
|
|
Apr 02
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.42%
|
$10,000
$1.02 P/Share
|